Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 14, 2025MedicinaOpen Access

From Better Diagnostics to Earlier Treatment: The Rapidly Evolving Alzheimer’s Disease Landscape

View Full Paper
Ask AI
Bookmark
Share

Authors

ABAnastasia BougeaMDManuel Debasa‐MouceSGShelly Gulkarov

Discussion

Loading...

Member takes

Overview

Review explores biomarkers and therapeutics for Alzheimer's disease, suggesting new approaches to early detection and intervention.

Key Points

  • Classic neurodegenerative biomarkers are critical for improving diagnostic accuracy in alzheimer's disease, underscoring their growing importance.
  • Recent genome-wide association studies identified 37 loci linked to alzheimer's disease risk, highlighting genetic factors at play.
  • Innovative drug delivery methods are in development to effectively target the blood-brain barrier, enhancing treatment options for alzheimer's disease.
  • Challenges persist with the amyloid hypothesis, pointing to gaps in understanding underlying molecular mechanisms and treatment effectiveness.

Cite This Study

Bougea et al. (2025) studied this question.

synapsesocial.com/papers/68af56f4ad7bf08b1eadd097https://doi.org/10.3390/medicina61081462
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1[Current Status and Future Perspectives of Biomarkers in Alzheimer's Disease Diagnosis].2025
  2. 2From Amyloid to Synaptic Dysfunction: Biomarker-Driven Insights into Alzheimer’s Disease2025 · 11 citations
  3. 3Biomarkers and Stem Cell-based Therapeutics in Alzheimer’s Disease: Recent Advances and Future Directions2026
  4. 4Potential diagnostic markers in Alzheimer's disease: current perspectives and future directions2025 · 5 citations
  5. 5The Role of Blood-Based Biomarkers in Transforming Alzheimer’s Disease Research and Clinical Management: A Review2025 · 18 citations